IL136461A0 - Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine - Google Patents
Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamineInfo
- Publication number
- IL136461A0 IL136461A0 IL13646198A IL13646198A IL136461A0 IL 136461 A0 IL136461 A0 IL 136461A0 IL 13646198 A IL13646198 A IL 13646198A IL 13646198 A IL13646198 A IL 13646198A IL 136461 A0 IL136461 A0 IL 136461A0
- Authority
- IL
- Israel
- Prior art keywords
- antihistamine
- composition
- skin diseases
- treating respiratory
- leukotriene antagonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6863897P | 1997-12-23 | 1997-12-23 | |
| US7863898P | 1998-03-19 | 1998-03-19 | |
| PCT/US1998/026223 WO1999032125A1 (en) | 1997-12-23 | 1998-12-21 | Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL136461A0 true IL136461A0 (en) | 2001-06-14 |
Family
ID=26749192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13646198A IL136461A0 (en) | 1997-12-23 | 1998-12-21 | Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP1041990B1 (pl) |
| JP (2) | JP2001526232A (pl) |
| KR (1) | KR100737710B1 (pl) |
| CN (1) | CN1283115A (pl) |
| AR (1) | AR017224A1 (pl) |
| AT (1) | ATE331522T1 (pl) |
| AU (1) | AU758771B2 (pl) |
| BR (1) | BR9814417A (pl) |
| CA (1) | CA2315721C (pl) |
| CO (1) | CO4980868A1 (pl) |
| CZ (1) | CZ301349B6 (pl) |
| DE (1) | DE69835103T2 (pl) |
| DK (1) | DK1041990T3 (pl) |
| ES (1) | ES2263229T3 (pl) |
| HK (1) | HK1027502A1 (pl) |
| HU (1) | HUP0101369A3 (pl) |
| ID (1) | ID26390A (pl) |
| IL (1) | IL136461A0 (pl) |
| MY (1) | MY121744A (pl) |
| NO (1) | NO20003288L (pl) |
| NZ (1) | NZ520907A (pl) |
| PE (1) | PE20000126A1 (pl) |
| PL (1) | PL193131B1 (pl) |
| PT (1) | PT1041990E (pl) |
| SA (1) | SA99200013B1 (pl) |
| SK (1) | SK286103B6 (pl) |
| WO (1) | WO1999032125A1 (pl) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6303632B1 (en) | 1992-09-03 | 2001-10-16 | Sepracor Inc. | Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients |
| DK0920865T3 (da) | 1992-09-03 | 2004-04-19 | Sepracor Inc | Farmaceutiske sammensætninger indeholdende norastemizol |
| US7214683B1 (en) | 1994-12-30 | 2007-05-08 | Sepracor Inc. | Compositions of descarboethoxyloratadine |
| US7211582B1 (en) | 1994-12-30 | 2007-05-01 | Sepracor Inc. | Methods for treating urticaria using descarboethoxyloratadine |
| US6194431B1 (en) * | 1998-04-14 | 2001-02-27 | Paul D. Rubin | Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| US6384038B1 (en) | 1998-04-14 | 2002-05-07 | Sepracor Inc. | Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants |
| US6248308B1 (en) | 1998-04-14 | 2001-06-19 | Sepracor Inc. | Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma |
| IT1303671B1 (it) | 1998-07-28 | 2001-02-23 | Nicox Sa | Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio |
| EP1000623A1 (en) * | 1998-09-29 | 2000-05-17 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Use of epinastine as antitussivum |
| EP1118327A4 (en) * | 1998-09-30 | 2006-08-02 | Ono Pharmaceutical Co | PREVENTIVE AND / OR THERAPEUTIC AGENTS FOR THE TREATMENT OF SINUSITIS. |
| US20020198246A1 (en) | 1998-09-30 | 2002-12-26 | Ono Pharmaceutical Co., Ltd. | Agent for preventing and/or treating sinusitis |
| JP2003521515A (ja) * | 2000-02-03 | 2003-07-15 | シェーリング コーポレイション | アレルギー状態および炎症状態の処置 |
| US7405223B2 (en) | 2000-02-03 | 2008-07-29 | Schering Corporation | Treating allergic and inflammatory conditions |
| DE10007203A1 (de) * | 2000-02-17 | 2001-08-23 | Asta Medica Ag | Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis |
| JP2002087963A (ja) * | 2000-09-08 | 2002-03-27 | Nippon Boehringer Ingelheim Co Ltd | 直接打錠により製造されたエピナスチン含有錠剤 |
| PE20020324A1 (es) * | 2000-10-06 | 2002-06-18 | Boehringer Ingelheim Int | Nuevas composiciones farmaceuticas que contienen epinastina y pseudoefedrina |
| US20020094345A1 (en) | 2000-10-06 | 2002-07-18 | Sara Abelaira | Pharmaceutical compositions containing epinastine and pseudoephedrine |
| JP4074427B2 (ja) | 2000-12-18 | 2008-04-09 | 株式会社栃木臨床病理研究所 | 子宮内膜症の予防又は治療薬 |
| US20020198228A1 (en) * | 2001-04-03 | 2002-12-26 | Kaura Sita R. | Composition and method for the treatment of respiratory desease |
| GB0115181D0 (en) * | 2001-06-20 | 2001-08-15 | Glaxo Group Ltd | Novel use |
| JP2004534820A (ja) * | 2001-06-20 | 2004-11-18 | シェーリング コーポレイション | 鼻うっ血および鼻閉塞の処置のための抗ヒスタミン薬 |
| DE60232445D1 (de) | 2001-06-28 | 2009-07-09 | Ucb Farchim Sa | Cetirizin und pseudoephedrin enthaltende tablette |
| MY148466A (en) | 2001-10-26 | 2013-04-30 | Merck Frosst Canada Ltd | Granule formulation |
| WO2003101434A2 (en) * | 2001-12-21 | 2003-12-11 | Sampad Bhattacharya | Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor |
| AU2003237253A1 (en) * | 2002-05-29 | 2003-12-19 | Aventis Pharmaceuticals Holdings Inc. | Method of treating asthma using fexofenadine |
| DE60319227T2 (de) * | 2002-07-02 | 2009-05-07 | Ucb Farchim S.A. | Diarylmethylpiperazines als prophylaktische oder therapeutische mittel gegen virale myocarditis |
| MXPA05005326A (es) * | 2002-12-06 | 2005-10-10 | Ucb Farchim Sa | Tableta que comprende efletirizina y pseudoefedrina. |
| WO2004087095A2 (es) * | 2003-03-31 | 2004-10-14 | Osmotica Costa Rica, Sociedad Anonima | Dispositivo osmótico que contiene zafirlukast y un antagonista h1 |
| EP1468696A1 (en) * | 2003-04-17 | 2004-10-20 | Boehringer Ingelheim International GmbH | Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases |
| WO2005030331A1 (en) * | 2003-09-26 | 2005-04-07 | Fairfield Clinical Trials, Llc | Combination antihistamine medication |
| JP2007530481A (ja) * | 2004-03-24 | 2007-11-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | エピナスチン及び１又は２以上の追加のミネラル又は１又は２以上の生薬のコンビネーションを含む皮膚疾患の治療用医薬組成物 |
| TR200806298A2 (tr) | 2008-08-22 | 2010-03-22 | Bi̇lgi̇ç Mahmut | Farmasötik formülasyon |
| KR101801864B1 (ko) * | 2010-06-16 | 2017-11-27 | 인플래머토리 리스폰스 리서치, 아이엔씨. | 인플루엔자, 감기 및 염증의 치료에서 레보세티리진 및 몬테루카스트의 용도 |
| US9617517B2 (en) | 2011-05-02 | 2017-04-11 | National University Corporation Kumamoto University | Small chemical compound which promotes induction of differentiation of stem cells into insulin-producing cells and method for inducing differentiation of stem cells into insulin-producing cells using said small chemical compound |
| KR20130009553A (ko) * | 2011-07-15 | 2013-01-23 | 한미약품 주식회사 | 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제 |
| WO2013058527A2 (ko) * | 2011-10-18 | 2013-04-25 | 주식회사 네비팜 | 류코트리엔 길항제와 에피나스틴의 복합제제 |
| KR101278572B1 (ko) * | 2011-10-18 | 2013-06-25 | 주식회사 네비팜 | 류코트리엔 길항제와 에피나스틴의 복합제제 |
| EP3308835B1 (en) | 2013-03-13 | 2020-01-01 | Inflammatory Response Research, Inc. | Use of levocetirizine and montelukast in the treatment of traumatic injury |
| ES2745041T3 (es) | 2013-03-13 | 2020-02-27 | Inflammatory Response Res Inc | Uso de levocetirizina y montelukast en el tratamiento de trastornos autoinmunitarios |
| KR20160125283A (ko) | 2013-03-13 | 2016-10-31 | 인플래머토리 리스폰스 리서치, 아이엔씨. | 레보세티리진 및 몬테루카스트의 혈관염의 치료 용도 |
| US9636318B2 (en) * | 2015-08-31 | 2017-05-02 | Banner Life Sciences Llc | Fumarate ester dosage forms |
| KR102356601B1 (ko) | 2014-06-10 | 2022-01-27 | 지엘팜텍주식회사 | 슈도에페드린을 함유하는 방출조절 펠렛 조성물 |
| JP2017526728A (ja) | 2014-09-15 | 2017-09-14 | インフラマトリー・レスポンス・リサーチ・インコーポレイテッド | 炎症介在性状態の治療におけるレボセチリジン及びモンテルカスト |
| US9981039B2 (en) | 2015-05-29 | 2018-05-29 | Accolade Pharma Llc | Composition, its preparation and method of use in treating skin disorders |
| US20200360317A1 (en) * | 2016-05-17 | 2020-11-19 | Proponent Biotech Gmbh | Carboxylic acids for treating/preventing a skin disease |
| KR102430892B1 (ko) * | 2016-05-17 | 2022-08-09 | 프로포넌트 바이오테크 게엠베하 | 비강 울혈을 치료/예방하기 위한 카르복실산 |
| WO2021142062A1 (en) | 2020-01-10 | 2021-07-15 | Banner Life Sciences Llc | Fumarate ester dosage forms with enhanced gastrointestinal tolerability |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
| US4662880A (en) * | 1986-03-14 | 1987-05-05 | Alza Corporation | Pseudoephedrine, brompheniramine therapy |
| US4810502A (en) * | 1987-02-27 | 1989-03-07 | Alza Corporation | Pseudoephedrine brompheniramine therapy |
| US5276044A (en) * | 1991-08-14 | 1994-01-04 | Allergan, Inc. | Leukotriene receptor antagonist and antihistamine complex pharmaceutical compositions |
| DE4203201A1 (de) * | 1992-02-05 | 1993-08-12 | Boehringer Ingelheim Kg | Neue amidinderivate, ihre herstellung und verwendung |
| HU216191B (hu) * | 1992-02-05 | 1999-05-28 | Boehringer Ingelheim Kg | Eljárás új amidinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
| US5270324A (en) * | 1992-04-10 | 1993-12-14 | Merck Frosst Canada, Inc. | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
| US5595997A (en) * | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| JPH08325265A (ja) * | 1995-05-29 | 1996-12-10 | Fujisawa Pharmaceut Co Ltd | チアゾリルベンゾフラン誘導体の製造方法、および該製造方法に用いられる化合物 |
| EP0780127A1 (en) * | 1995-12-19 | 1997-06-25 | The Procter & Gamble Company | A nasal spray containing a steroid and a antihistamine |
| PL328074A1 (en) * | 1996-02-08 | 1999-01-04 | Merck & Co Inc | Therapeutical method and pharmaceutic composition |
| AU3153797A (en) * | 1996-06-04 | 1998-01-05 | Procter & Gamble Company, The | A nasal spray containing an intranasal steroid and an antihistamine |
| US5900421A (en) * | 1997-02-11 | 1999-05-04 | Sepracor Inc. | Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine |
| EP0979105A1 (en) * | 1997-04-30 | 2000-02-16 | Warner-Lambert Company | Topical nasal antiinflammatory compositions |
-
1998
- 1998-12-21 CN CN98812638A patent/CN1283115A/zh active Pending
- 1998-12-21 SK SK897-2000A patent/SK286103B6/sk not_active IP Right Cessation
- 1998-12-21 CA CA002315721A patent/CA2315721C/en not_active Expired - Fee Related
- 1998-12-21 ID IDW20001217A patent/ID26390A/id unknown
- 1998-12-21 MY MYPI98005791A patent/MY121744A/en unknown
- 1998-12-21 WO PCT/US1998/026223 patent/WO1999032125A1/en not_active Application Discontinuation
- 1998-12-21 HU HU0101369A patent/HUP0101369A3/hu unknown
- 1998-12-21 AU AU19071/99A patent/AU758771B2/en not_active Ceased
- 1998-12-21 JP JP2000525116A patent/JP2001526232A/ja active Pending
- 1998-12-21 IL IL13646198A patent/IL136461A0/xx not_active IP Right Cessation
- 1998-12-21 EP EP98963828A patent/EP1041990B1/en not_active Expired - Lifetime
- 1998-12-21 AT AT98963828T patent/ATE331522T1/de active
- 1998-12-21 DE DE69835103T patent/DE69835103T2/de not_active Expired - Lifetime
- 1998-12-21 AR ARP980106566A patent/AR017224A1/es not_active Application Discontinuation
- 1998-12-21 NZ NZ520907A patent/NZ520907A/en not_active IP Right Cessation
- 1998-12-21 BR BR9814417-0A patent/BR9814417A/pt not_active Application Discontinuation
- 1998-12-21 DK DK98963828T patent/DK1041990T3/da active
- 1998-12-21 ES ES98963828T patent/ES2263229T3/es not_active Expired - Lifetime
- 1998-12-21 PL PL341343A patent/PL193131B1/pl not_active IP Right Cessation
- 1998-12-21 PT PT98963828T patent/PT1041990E/pt unknown
- 1998-12-21 KR KR1020007006986A patent/KR100737710B1/ko not_active IP Right Cessation
- 1998-12-21 CZ CZ20002198A patent/CZ301349B6/cs not_active IP Right Cessation
- 1998-12-22 PE PE1998001265A patent/PE20000126A1/es not_active Application Discontinuation
- 1998-12-22 CO CO98075939A patent/CO4980868A1/es unknown
-
1999
- 1999-04-20 SA SA99200013A patent/SA99200013B1/ar unknown
-
2000
- 2000-06-22 NO NO20003288A patent/NO20003288L/no not_active Application Discontinuation
- 2000-10-13 HK HK00106523A patent/HK1027502A1/xx not_active IP Right Cessation
-
2010
- 2010-12-27 JP JP2010291255A patent/JP2011068679A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0101369A3 (en) | Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine | |
| EP1128832A4 (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND RELATED DISEASES | |
| EP1109580A4 (en) | METHOD FOR TREATING OR PREVENTING VIRAL INFECTIONS AND RELATED DISEASES | |
| EP1115286A4 (en) | METHOD FOR TREATING AND PREVENTING VIRAL INFECTIONS AND DISEASES RELATED TO THEM | |
| IL133784A (en) | Dolastatin 15 derivatives, pharmaceutical compositions comprising them and their use in medicaments for treating cancer | |
| IL136425A0 (en) | Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use | |
| EP1109548A4 (en) | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING BONE DISEASES USING TOCOTRIENOLE | |
| ZA200201819B (en) | Preventive and therapeutic agents for eye diseases. | |
| HK1040980A1 (zh) | 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途 | |
| AU5774699A (en) | Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders | |
| HUT74948A (en) | Use of p antagonist for producing pharmaceutical compositions for treating acne, rosacea and/or pubic arythema | |
| HUP0003478A3 (en) | Synergistic fungicidal compositions, their use and process for their preparation | |
| HRP980502B1 (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles, processes for their preparation and their use as medicaments | |
| EP0921803A4 (en) | METHOD FOR PREVENTING AND TREATING PESTVIRUS INFECTIONS AND RELATED DISEASES | |
| ZA200203435B (en) | Method and compositions for treating pulmonary diseases. | |
| HUP9904173A3 (en) | Pharmaceutical composition for treating viral diseases | |
| HUT74745A (en) | Pharmaceutical compositions containing p antagonist for treating pruritis, eye- and eyelid-acs and eye-and eyelid dysaesthesia | |
| AU2002215187A1 (en) | S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease | |
| SG65766A1 (en) | Composition for preventing and treating gingival diseases | |
| PL345068A1 (en) | Novel compounds derived from α-d-xylose, preparation method and therapeutic use | |
| GB9820631D0 (en) | Hair treatment composition, method and use | |
| HUP0203468A3 (en) | Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof | |
| HUP0102116A3 (en) | Paroxetine ascorbate, process for its preparation and its pharmaceutical use | |
| ZA9811731B (en) | Composition for treating respiratory and skin diseases | |
| EP0998934A4 (en) | REMEDIES AGAINST INTRAMEDULLARY DISEASES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |